News|Articles|October 1, 2025

Maypro announces distribution partnership with Tradichem Group

Listen
0:00 / 0:00

Key Takeaways

  • Maypro's partnership with Tradichem introduces Clonapure and Hipering to North America, targeting active nutrition and supplement manufacturing sectors.
  • Clonapure offers rapid absorption and performance benefits, supporting metabolic health, weight management, and muscle support.
SHOW MORE

Maypro partners with Tradichem to launch Clonapure, a fast-acting creatine complex, and Hipering granulation technology in North America.

Maypro disclosed in a recent press release that the company has obtained a new distribution partnership with Tradichem Group, along with its subsidiaries Florida Human Nutrition and Tradichem Industrial Services. Through the partnership, two technologies called Clonapure, which is a fast-acting clinically validated creatine complex, and Hipering, a patent granulation delivery technology, will be introduced into the North American market.1

Clonapure

Interest with creatine has been growing in active nutrition, metabolic support markets, women’s health, and sports performance sectors.1 Clonapure was created to have rapid absorption and performance benefits that have been clinically validated. The product was created by Florida Human Nutrition and consists of “creatine monohydrate, phosphocreatine, and phosphate in precise ratios to optimize intracellular creatine replenishment, enhance ATP production, and support sustained energy, power, and endurance.”1 The formula consistency also may help with overall metabolic health, weight management protocols, and muscle support.

“Creatine is experiencing remarkable growth beyond traditional sports nutrition, with increasing adoption in men’s and women’s health, active lifestyle, and metabolic support categories,” said Abhijit Natu, Vice President of Sales and Marketing at Maypro.1 “Clonapure® represents the next evolution in creatine supplementation—its fast-acting, clinically validated formulation not only enhances muscle performance and recovery but also addresses the needs of a wider range of consumers, including those on weight management protocols like Semaglutide. With its superior absorption and targeted intracellular support, Clonapure® offers brands a unique opportunity to deliver meaningful, science-backed benefits across diverse consumer segments.”

Hipering

Hipering techonology was designed by Tradichem Industrial Services. The platform helps with supplement manufacturing through turning fine powders which can be prone to experiencing machine adhesion, as well as poor flowability, to free-flowing, compressible granules.1 Utilizing this technology can remove the necessity of excipients, fillers, and synthetic binders which will allow for tablet quality improvement and clean label formulations.

“Hipering® modifies the physical properties of raw ingredients while maintaining purity and chemical integrity,” explained José Angel Maroñon, CEO of Tradichem Group. “Manufacturers can now achieve optimal production efficiency and product consistency without compromising on ingredient quality. Raw ingredients are transformed into a free-flowing, compressible form without the need for synthetic binders, fillers, or other excipients,” he explained.1

Maypro will be showcasing Clonapure and Hipering at SupplySide Global which is taking place in Las Vegas, Nevada, between October 29 to October 30, 2025. Attendees such as, contract manufacturers, product developers, brand leaders, formulators and more can visit Booth #5951, where they can learn more about these two technologies.

Maypro and HITLAB Create Discovery Launchpad Through Partnership

Maypro (Purchase, NY) has announced a partnership with HITLAB that combines the company’s expertise in nutraceuticals with HITLAB’s to leverage digital technology and AI to create a discovery launchpad that enhances the Maypro’s B2B and DTC wellness products and services. According to the company’s press release, the collaboration will involve multiple aspects of digital technology, including novel ingredient discovery, formulation optimization, personalized care, and efficient clinical trial processes.

“In today’s rapidly evolving digital landscape, our collaboration with HITLAB represents an exciting opportunity to harness technology’s transformative power in the pursuit of wellness,” said May Yamada-Lifton, CEO of Maypro Group, in a press release.2 “Together, we want to think of how to play in the greater wellness space and create a digitally dynamic company.”

An initial focus, says Maypro, will be to understand on how digital health solutions may help brands, consumers, and doctors be more educated on the nutritional needs of individuals as well as specific populations, and use this info to better address their needs.

References

  1. Maypro. Maypro announces strategic partnership with Tradichem Group https://www.maypro.com/blogs/press/maypro-announces-strategic-partnership-with-tradichem-group (accessed Oct 1, 2025).
  2. Krawiec, S. Maypro and Hitlab form partnership to harness digital health solutions to enhance products and services https://www.nutritionaloutlook.com/view/maypro-and-hitlab-form-partnership-to-harness-digital-health-solutions-to-enhance-products-and-services (accessed Oct 1, 2025).

Newsletter

From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.